Concepedia

Steven L. Chuck

SL

Statistics

Publications

26

Citations

4.3K

H-Index

22

Active since

1989

Affiliations

Gilead Sciences (United States)(Current)

Beth Israel Deaconess Medical Center

Harvard University

University of California, San Francisco

Université Paris Cité

Steven L. Chuck is an author at Gilead Sciences (United States) specializing in life sciences, antiviral therapy, and pharmacotherapy.

Publications per year

1989–2014

26

Publications

26

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

Joel E. Gallant, Edwin DeJesus, José Ramón Arribas et al. · New England Journal of Medicine · 2006 · 886 citations

, , +12

Long-term Therapy With Adefovir Dipivoxil for HBeAg-Negative Chronic Hepatitis B for up to 5 Years

Stephanos J. Hadziyannis, Nicolaos C. Tassopoulos, E. Jenny Heathcote et al. · Gastroenterology · 2006 · 882 citations · Full text

, , +13

Infections with<i>Cryptococcus neoformans</i>in the Acquired Immunodeficiency Syndrome

Steven L. Chuck, Merle A. Sande · New England Journal of Medicine · 1989 · 801 citations

, , +12

Adefovir Dipivoxil for Wait-Listed and Post–Liver Transplantation Patients with Lamivudine-Resistant Hepatitis B

Eugene R. Schiff, Ching‐Lung Lai, Stephanos J. Hadziyannis et al. · Liver Transplantation · 2007 · 236 citations · Full text

, , +11

Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study

Jean‐Michel Molina, Anthony LaMarca, Jaime Andrade‐Villanueva et al. · The Lancet Infectious Diseases · 2011 · 172 citations

, , +15

1–5 of 26